Kontakt Impressum

Recently published:

Lubitz, L.J.; Haffner, M.P.; Rieger, H.; Leneweit, G. Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells. Pharmaceutics 2024, 16, 1112. https://doi.org/10.3390/pharmaceutics16091112

Lubitz, L.J.; Haffner, M.P.; Rieger, H.; Leneweit, G. Elevated Cellular Uptake of Succinimide- and Glucose-Modified Liposomes for Blood–Brain Barrier Transfer and Glioblastoma Therapy. Biomedicines 2024, 12, 2135. https://doi.org/10.3390/biomedicines12092135

Larissa J. Lubitz, Harden Rieger and Gero Leneweit Emulsifying mechanisms of phospholipids in high-pressure homogenization of perfluorocarbon nanoemulsions. Soft Matter, DOI: 10.1039/d4sm00828f

 


Carl Gustav Carus-Institut der Gesellschaft zur Förderung der Krebstherapie e. V. | Allmendstr. 55 - 75223 Niefern-Öschelbronn | Tel.: 07233 7043-101 | www.carus-institut.de